Literature DB >> 11106076

Hemosiderotic fibrohistiocytic lipomatous lesion: ten cases of a previously undescribed fatty lesion of the foot/ankle.

C Marshall-Taylor1, J C Fanburg-Smith.   

Abstract

We address the clinicopathologic features of a previously undescribed heavily-pigmented spindle cell proliferation within a circumscribed benign lipomatous lesion that occurs mainly in the ankle region of older females. Patients with "lipoma with fibrohistiocytic proliferation" were retrieved from our files. Slides and clinical information were reviewed, and immunohistochemistry was performed (n = 5). Ten patients with hemosiderotic fibrohistiocytic lipomatous lesions were identified. All cases demonstrated a well-circumscribed fatty lesion with random focal proliferations of plump, slightly pleomorphic spindled cells, scattered inflammatory cells, and abundant iron pigment. The spindled cells had vesicular nuclei with indistinct nucleoli; occasional hyperchromatism was observed. No nuclear cytoplasmic inclusions were identified. The spindled component had a reactive appearance. In most cases, the fatty component, with homogeneously sized adipocytes, predominated. The lesions occurred in the foot/ankle region (8/10, one each cheek and hand) of primarily females (8/10) with a mean age of 50.6 years (range 42-63 years), size of 7.7 cm (range 2.5-17 cm), and prior duration of 3.1 years. Seven of eight patients had a history of prior trauma. The spindled component was positive for vimentin, calponin, CD34, and occasionally KP-1 or lysozyme and negative for caldesmon, S100, and desmin. Follow-up on eight patients revealed four with recurrences or residual disease over three years, requiring re-excision. No cases metastasized or caused patient death (mean 12 years, range 1-23 years). We describe a predominantly fatty lesion that is hemosiderin rich with a "fibrohistiocytic" proliferation, composed of histiocytes, myofibroblasts, and C34-positive fibroblasts, which occurs predominantly in the ankle region of middle-aged females. We believe that this is a reactive process due to antecedent trauma, the inflammatory cells, hemosiderin, mixed spindled cells, and homogeneous non-neoplastic appearance of the fat. HFLL can be distinguished from previously described lesions. Correct identification of hemosiderotic fibrohistiocytic lipomatous lesion is important, as it may locally recur.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106076     DOI: 10.1038/modpathol.3880221

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

1.  Pleomorphic hyalinizing angiectatic tumor: imaging findings.

Authors:  Ty K Subhawong; Andrea P Subhawong; Elizabeth A Montgomery; Laura M Fayad
Journal:  Skeletal Radiol       Date:  2012-06-03       Impact factor: 2.199

Review 2.  Review of common and unusual causes of lateral ankle pain.

Authors:  Surabhi Choudhary; Eugene McNally
Journal:  Skeletal Radiol       Date:  2010-10-24       Impact factor: 2.199

3.  Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.

Authors:  William B Laskin; John F Fetsch; Markku Miettinen
Journal:  Am J Surg Pathol       Date:  2014-01       Impact factor: 6.394

4.  Palmar atypical lipomatous tumour with spindle cell features (well-differentiated spindle cell liposarcoma): a rare neoplasm arising in an unusual anatomical location.

Authors:  T Mentzel; J Toennissen; A Rütten; J Schaller
Journal:  Virchows Arch       Date:  2005-02-18       Impact factor: 4.064

5.  Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.

Authors:  Cristina R Antonescu; Lei Zhang; G Petur Nielsen; Andrew E Rosenberg; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2011-06-29       Impact factor: 5.006

6.  Radiological imaging features and clinicopathological correlation of hemosiderotic fibrolipomatous tumor: experience in a single tertiary cancer center.

Authors:  Dearbhail O'Driscoll; Edward Athanasian; Meera Hameed; Sinchun Hwang
Journal:  Skeletal Radiol       Date:  2014-12-21       Impact factor: 2.199

7.  Hemosiderotic fibrohistiocytic lipomatous lesion: clinical correlation with venous stasis.

Authors:  Dmitry V Kazakov; Radek Sima; Michal Michal
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

Review 8.  Case report: hemosiderotic fibrohistiocytic lipomatous lesion: a clinicopathologic characterization.

Authors:  Vincent M Moretti; John S J Brooks; Christian M Ogilvie
Journal:  Clin Orthop Relat Res       Date:  2010-02-02       Impact factor: 4.176

9.  Haemosiderotic fibrohistiocytic lipomatous lesion/tumour of the foot: MRI and histopathology.

Authors:  Andrew T West; Andoni P Toms; Joseph Murphy; Mohammed Sultan
Journal:  Skeletal Radiol       Date:  2007-10-30       Impact factor: 2.199

10.  Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot.

Authors:  Abbas Agaimy; Norbert Meidenbauer; William R Sukov; Robert Stoehr; Michael Vieth; Frank Roemer; Robert Grützmann; Andrew L Folpe
Journal:  Virchows Arch       Date:  2021-08-14       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.